Unike Of Japan Develops Generic Drug Support System
This article was originally published in PharmAsia News
With an April 1 deadline looming for Japan to change prescription forms in an effort to boost generic drug use, Tokyo-based Unike Software Research Co. has launched GenericMaster, a database that provides drug information for physicians and pharmacists. GenericMaster compares branded names and generic drugs on factors such as quality, safety, economic efficiency and distribution, aiming to provide patients with accurate and specific information. Utilizing knowhow in developing insurance dispensing systems, the GenericMaster also provides information on insurance coverage and the patient's portion of payment, with a goal of making it easier for patients to choose safe and economically efficient generic drugs. (Click here for more-J apanese language
You may also be interested in...
Celltrion's Truxima has become the first rituximab biosimilar, and just the second biosimilar overall, to be prequalified by the World Health Organization.
Fresenius Kabi’s Idacio biosimilar adalimumab rival to Humira will from the start of June be marketed in Germany by Medac, following a deal between the two companies.
Coronavirus Update: Roche Launches Remdesivir Plus Actemra Trial, GSK Plans 1bn Vaccine Adjuvant Doses
Roche is teaming up with Gilead on the combination trial, aiming to improve on results of remdesivir alone, which has failed to show mortality benefits in COVID-19 patients.